An invitation-only roundtable convening leading industry stakeholders to debate one mission-critical challenge facing biopharma

The 2026 Forum takes place just after the U.S. midterms and as PDUFA reauthorization negotiations ramp up, a narrow window to shape the first-in-human agenda

BioCentury convenes and moderates the Forum with guidance from its Scientific Advisory Board. Editorial control rests exclusively with BioCentury

Attendance is by invitation only. Invitations go to leaders whose expertise bears directly on the meeting's topic.

No. There is no fee to attend. BioCentury and a select group of underwriters cover Forum costs.

Yes. Email with your role and interest, and the team will review requests as seats allow.

Participants may use what is said in the room, but may not identify who said it or the organization they represent.

Yes. A limited number of underwriting positions are available for each meeting. Contact conferences@biocentury.com.

An opportunity to join BioCentury in leading the discussion on a mission-critical challenge facing biopharma. Underwriters receive tickets to the Forum and dinner.

Dec. 2 is the "Bending the Curve" networking dinner. Dec. 3 is the full-day roundtable, followed by a live podcast recording and closing reception.

Yes. The "BioCentury This Week" special edition episode is recorded live on Dec. 3 and published on BioCentury's podcast channels.

Yes. BioCentury publishes a post-Forum white paper capturing the debate and its recommendations, with no attribution to individuals.